Open AccessPSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
Author(s) -
Christine Ferrara-Cook,
Rosa Luo,
Eduardo de la Torre,
Yan Wang,
Stephen F. Betz,
Ajay Madan,
Scott Struthers,
Ulrike Hövelmann,
Tim Heise,
Alan Krasner
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.850
Subject(s) - medicine , endocrinology , insulin , congenital hyperinsulinism , hypoglycemia , glibenclamide , pharmacokinetics , pharmacodynamics , agonist , bolus (digestion) , basal (medicine) , diabetes mellitus , hyperinsulinism , receptor , insulin resistance